Indications
Treatment of non-resectable grade II or III mast cell tumours in dogs.
Composition
- Active substance
- paclitaxel
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Paccal Vet
- Active substance
- paclitaxel
- Group
- Veterinary medicines
- Marketing authorisation holder
- Oasmia Pharmaceutical AB
- Status
- Application withdrawn
- EMA product number
- EMEA/V/C/002237
EMA designations
- Orphan medicine